Release Date: February 17, 2021
Expiration Date: February 17, 2022

Expected time to complete this activity as designed: 15 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

Mutational testing is an integral part of the management of myeloproliferative neoplasms (MPNs), as results from this assessment can both guide treatment selection and provide prognostic information. In this article, Dr. Aaron Gerds discusses best practice regarding the utility of mutational testing in clinical practice when treating patients with MPNs.

Target Audience

This activity is designed for multidisciplinary healthcare providers in the community setting, including hematologists, oncologists, pharmacists and other allied healthcare professionals who provide care to patients with myeloproliferative neoplasms.

Learning Objective

Upon completion of this educational activity, participants should be able to:

• Describe underlying genetic alterations that can affect a patient’s diagnosis and direct individual management strategies

Agenda

MPN Driver Genes and the Importance of Molecular Genetic Testing - Aaron T. Gerds, MD

Instructions for Participation and Credit

This activity is eligible for credit through February 17, 2022. After this date, this activity will expire and no further credit will be awarded.

1. Read the target audience, learning objectives, and faculty disclosures.
2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
3. Complete the educational content as designed.
4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
6. Certificates for CME may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Aaron T. Gerds, MD
Associate Professor of Medicine
Cleveland Clinic Learner College of Medicine
Case Western Reserve University
Cleveland, Ohio

Dr. Aaron Gerds received his medical degree from Loyola University of Chicago, Stritch School of Medicine, where he also completed his internal medicine residency/chief residency. He went on to pursue a master of science degree in clinical research methods and epidemiology from Loyola University of Chicago, and a hematology and oncology fellowship at the University of Washington, Fred Hutchinson Cancer Research Center. Dr. Gerds is an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, and Deputy Director for Clinical Research at the Cleveland Clinic Taussig Institute.

Dr. Gerds is a diplomate in internal medicine, oncology, and hematology from the American Board of Internal Medicine. He holds memberships in the American Society of Clinical Oncology, American Society of Hematology, American Society for Blood and Marrow Transplantation, Society of Hematologic Oncology, SWOG Cancer Research Network, and the MDS Foundation. Dr. Gerds is on the editorial board of the Journal of the National Comprehensive Cancer Network, Cancer Treatment and Research Communications, and the National Cancer Institute Physician Data Query (PDQ), and is a reviewer for many peer-reviewed journals. Dr. Gerds’ clinical and research interests focus on optimizing current treatments, and developing new therapies for patients with myeloproliferative disorders and other myeloid neoplasia.

Accreditation

CME CREDIT Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation Statement: MediCom Worldwide, Inc. designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE CREDIT MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for .25 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-21-003-H01-P. Knowledge-based CPE activity. In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program. International Pharmacy Preceptors and Canadian Pharmacists: If you are in need of e-Profile ID to participate in an ACPE approved activity, please contact NABP customer service for further assistance as special handling is necessary. NABP customer service can be reached at (847) 391-4406.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Aaron Gerds has received honoraria related to formal advisory activities from Constellation Pharmaceuticals, CTI BioPharma Corp., Galecto Biotech, PharmaEssentia Corporation, and Promedior, Inc.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, Isabelle Vacher, Vice President of Educational Strategy, Wilma Guerra, Program Director, and Andrea Mathis, Project Manager, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at [email protected]

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Bristol-Myers Squibb and Incyte Corporation.

©2021 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.